Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 698 of 6351
-
One shot for two viruses? combo COVID-Flu vaccine moves forward
Vaccine CompletedStudy VBT00001 is planned to be a Phase 1/2, randomized, modified double-blind, active-controlled, multi-center study to be conducted in approximately 980 adults aged 50 years and older in the United States. The purpose of the study is to assess the safety and immunogenicity of …
Phase 1/2 • Sponsor: Sanofi • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
Magic mushroom therapy targets anorexia in young adults
Symptom relief Recruiting nowThis is a single site trial of psilocybin therapy for the treatment of refractory Anorexia Nervosa in young adults. The psilocybin therapy will include three preparatory sessions, psilocybin dosing session one (20mg), two integration sessions, psilocybin dosing session two (up to…
Phase 2 • Sponsor: Marissa Raymond-Flesch, MD, MPH • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New pill could help kids fight obesity – clinical trial underway
Disease control Recruiting nowThe purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New lung cancer cocktail aims to shrink tumors before surgery
Disease control OngoingThis study will enroll adult participants with early-stage (stage II-IIIB) non-small cell lung cancer for whom surgery is planned. The aim is to find out whether an investigational treatment (consisting of the immunotherapy drug cemiplimab plus chemotherapy plus a third drug) wo…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New daily pill could help teens shed pounds in major trial
Disease control Recruiting nowThe main purpose of this study, performed under Master Protocol J4M-MC-PWMP (NCT06672549), is to evaluate the efficacy, safety, and pharmacokinetics of orforglipron once daily oral versus Placebo in adolescent participants with obesity, or overweight with related comorbidities. P…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Do vegan yogurts and meat substitutes really boost your gut?
Knowledge-focused Recruiting nowThe diet is assumed to contribute to many of our present non-communicable diseases. Vegetarian products are instead considered to be health promoting, However, it is not verified that the modern vegetarian and vegan products are healthier than the ones they are meant to replace. …
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
New combo therapy aims to fight hard-to-treat prostate cancer
Disease control Recruiting nowThe goal of this clinical trial is to study the combination of SX-682 plus enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC) who have failed prior therapy with androgen receptor pathway inhibitors.
Phase 2 • Sponsor: Syntrix Biosystems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo aims to tackle tough lymphomas
Disease control Recruiting nowThis is a Phase II single-center open label trial of the combination of ATRA and pembrolizumab treatment in patients with histologically proven, relapsed or refractory Hodgkin Lymphoma or B-Non-Hodgkin-lymphoma.
Phase 2 • Sponsor: Rita Assi • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for older leukemia patients: drug combo aims for higher remission
Disease control Recruiting nowThis study is a multicenter, prospective, randomized, controlled clinical trial, observing the efficacy and safety of the CACAG+Venetoclax regimen (Chidamide + Azacitidine + Aclarubicin + Cytarabine + Recombinant Human Granulocyte Colony-Stimulating Factor + Venetoclax) in elderl…
Phase 3 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New trial aims to improve pregnancy outcomes with smart glucose monitoring
Disease control Recruiting nowThere are a few ongoing large randomized controlled trials (RCT's) on continuous glucose monitoring (CGM) in women with gestational diabetes (GDM) powered for pregnancy outcomes. However, none of these studies included women diagnosed with early GDM. The CORDELIA trial is a Belgi…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a simple workout routine tame IBD symptoms?
Symptom relief Recruiting nowThe goal of this Randomised controlled trial is to investigate the effect of exercise on changes in quality of life in in patients with clinical quiescent Inflammatory bowel Disease. The main question it aims to answer * The Relationship Between Moderate-Intensity Exercise and Q…
Sponsor: Mahidol University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New hope for myeloma: adaptive trial tests smarter drug combos
Disease control OngoingThis trial is an adaptive platform trial. The structure of the protocol allows the trial to evolve over time. Multiple investigational arms will be included within the trial under a Master Protocol (MP). These investigational arms may be added as appendices at different times dep…
Phase 2 • Sponsor: Multiple Myeloma Research Consortium • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New Weight-Loss drug shows promise in large trial
Disease control CompletedThe main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.
Phase 3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Blood test could predict which pancreatic cancer patients benefit from chemo
Knowledge-focused Recruiting nowThis study aims to develop and validate a predictive microRNA (miRNA) panel to assess the response to neoadjuvant chemotherapy (NACT) in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC).
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Could a common arthritis drug help prevent miscarriages?
Disease control Recruiting nowThe goal of this clinical trial is to learn if combined treatment of levothyroxine and hydroxychloroquine would improve the live birth of euthyroid women with thyroid peroxidase antibodies and unexplained recurrent pregnancy loss. Researchers will compare combined treatment of l…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a Freeze-Dried vaccine shield all ages from hib?
Vaccine OngoingThis trial is a randomized, partially blinded, positively controlled phase I clinical study. A total of 160 persons aged 18-59 years, 1-5 years, 6-11 months and 2 months (60-89 days) will be recruited into the trial, and the enrollment will be done according to the progression of…
Phase 1 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Aug 08, 2026 00:03 UTC
-
Immunotherapy boost for hard-to-treat bowel cancer?
Disease control Recruiting nowThe aim of this study is to evaluate the efficacy of the addition of Atezolizumab to FOLFOXIRI plus bevacizumab as first line treatment of patients with pMMR and Immunoscore IC-high metastatic colorectal cancer in terms of Progression Free Survival (PFS).
Phase 3 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug cocktail takes on deadly brain cancer
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the safety and tolerability of avutometinib and defactinib and to determine the preliminary antitumour activity of avutometinib and defactinib administered at the recommended Phase 2 dose (RP2D). In the Phase 1b of this study para…
Phase 1/2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug cocktail aims to stop bladder cancer recurrence after surgery
Disease control Recruiting nowThis is a phase 2 study, single-arm study of adjuvant combination therapy with Sacituzumab Govitecan and Nivolumab in patients with muscle-invasive urothelial carcinoma of the bladder, ureter, or upper tract, who are high risk for cancer recurrence post curative-intent surgery ba…
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can a nerve zap and a phone app stop teen suicide?
Symptom relief OngoingSuicidal thoughts, suicide attempts, and suicide are increasingly common in adolescence. Current face-to-face prevention approaches are of limited effectiveness, rely on extensive resources, and are at odds with adolescents' digital preferences. We will evaluate two unconvention…
Sponsor: University of Notre Dame • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC